JB Chemicals Acquires Several Sanzyme Brands

The $83m Transaction Is Expected To Close Within The Next Two Weeks

JB Chemicals has purchased a number of leading brands from Sanzyme, which it plans to scale up and institutionalize within India. The transaction, worth over $80m, is expected to close within the next two weeks.

Close-up of bottles on conveyor belt in factory
JB Chemicals has experienced a conveyor belt of executive changes since its acquisition by KKR • Source: Alamy

JB Chemicals & Pharmaceuticals Ltd. has acquired a number of brands in the probiotics, therapeutic nutraceuticals and reproductive health markets from Sanzyme, in a transaction valued at INR6.28bn ($83.4m). The deal is expected to be completed within the next two weeks following customary closing formalities, having been signed off at a 25 January board meeting.

“Leading brands like Sporlac, Lobun, Oxalo, Pubergen, Nano-leo and Gynogen will now be part of the JBCPL franchise,” JB Chemicals...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Deals

More from Business